Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.
about
Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trialDietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancerInsulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}.Statins in the treatment of polycystic ovary syndrome.The polycystic ovary syndrome: treatment with insulin sensitizing agents.On the association between valproate and polycystic ovary syndrome.Polycystic ovarian syndrome in women with epilepsy: a review.Testosterone, not 5α-dihydrotestosterone, stimulates LRH-1 leading to FSH-independent expression of Cyp19 and P450scc in granulosa cells.Effects of caloric intake timing on insulin resistance and hyperandrogenism in lean women with polycystic ovary syndrome.Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndromeComparison of 25-hydroxyvitamin D and Calcium Levels between Polycystic Ovarian Syndrome and Normal Women.Activation of K(ATP) channels suppresses glucose production in humans.Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth.Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome.The pathogenetic enigma of polycystic ovary syndrome.Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?Menstrual health and the metabolic syndrome in adolescents.Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism.Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity.Management of polycystic ovary syndrome.Hirsutism: definitions and etiology.PCOS in adolescence and type 2 diabetes.Polycystic ovary syndrome and insulin: our understanding in the past, present and future.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia.Reduction of endogenous, ovarian and adrenal androgens with ketoconazole does not alter insulin response in the polycystic ovary syndrome.Metformin in normal-weight hirsute women with polycystic ovary syndrome with normal insulin sensitivity.Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome.Tissue insulin sensitivity and body weight in polycystic ovary syndrome.Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome.Inositolphosphoglycans (IPGs) as mediators of insulin's steroidogenic actions.Endocrine-metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome.Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome.The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
P2860
Q22242102-3AD2A52F-C838-4D0D-BC20-3DDE756AA7C0Q28069088-7C8A2DDD-A997-4268-9DF3-615B6E26A953Q33569169-E184B7F2-34DB-4EE3-B4FE-138CBE3658AEQ33736175-E0D24A80-CCFD-41CC-818A-5ADB3D748042Q33789151-0DE4B763-288C-4351-99B1-DE3A6CE12D5AQ34163132-2765D885-8CBA-435D-A24F-BE616227D488Q34301379-F8564CC9-66C9-40D4-A6CA-A9662016502CQ34345051-2F00FE2C-FB9F-412B-AC38-F249FF95233CQ34712155-8BE157F6-5ABE-46A4-84BE-84AE6D667D3DQ34729110-17ED02B6-B4F7-4075-B005-3912230BCB7FQ35117211-EDD4BED7-6285-4755-B712-72ECA3EF69A3Q35538983-DBE621CB-7E23-4CE8-97AC-43F8F6207F18Q35578609-8F5816FA-2CA0-4614-9008-62A9C7265A7EQ35599772-C20F2D53-2CC0-47CB-9854-0FED40BB2AC3Q36182579-702A1121-331E-4CCA-AB3F-DB507FD70CD6Q36303511-A7CB8F43-85D3-445E-AD46-0ABC2D24F8D7Q36519648-6E533B33-2ACE-472F-8208-3FB3DBBDC04BQ36556867-8F09EFAA-DCB5-4370-BFD3-1B5D3007A236Q36673559-FC5078F1-D2B9-4736-9431-F5505705BD44Q37198401-EA3EFF68-6B1A-4048-8120-BCE260C15889Q37310914-0E0D3A1C-8B7B-47DE-98B4-A530721AC687Q37355743-EBB1AEFB-C83C-4242-B53C-A8E82682AF50Q37608413-5B1D0396-236E-4A8D-A830-0ADCDF5BB78DQ37936444-A5DB72BB-B22D-4DC2-AB89-CA0FD78D6CDDQ38268267-68DD1F0E-F91A-4D93-8683-3B3EF07D36A9Q38380065-D821E570-1EF0-412A-975F-5983C2439CD6Q38641190-82742C0B-B689-4158-9C91-8B1707467E38Q42476937-440B9337-A6C7-4A8E-AD42-03DD97981423Q42476947-287C8DB2-260D-486C-A177-8362BF415256Q42481258-775B8EFB-326E-4406-8570-B378A7E2F840Q42489607-C877C73E-611B-41F6-BB61-DC054B1BD4AEQ42513845-4984E14E-E4C4-4415-BC2E-17221AC3F58BQ43009548-E61F08A5-E8DA-4F73-8C4A-C8B3FB698974Q43263695-C0E9F5FE-0B2B-4190-A4FF-7C785A5B802FQ43725577-D7421B57-AEC1-4604-8858-0A34656D2920Q44695733-FF5AF41B-3BEB-461E-8DF3-966119ED3BC1Q44859933-36299C26-4A77-4083-AD6B-FA6DC110984AQ46877696-79B4A11F-1D82-4B0B-AECA-90B0FC291EA8Q48006996-6E186903-01FD-4850-A030-365643799963Q48354384-6E81E088-328D-491D-AECD-D912B130793B
P2860
Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Suppression of serum insulin b ...... ith polycystic ovary syndrome.
@en
type
label
Suppression of serum insulin b ...... ith polycystic ovary syndrome.
@en
prefLabel
Suppression of serum insulin b ...... ith polycystic ovary syndrome.
@en
P2093
P921
P356
P1476
Suppression of serum insulin b ...... ith polycystic ovary syndrome.
@en
P2093
Barlascini CO
Blackard WG
Nestler JE
Plymate SR
Steingold KA
P304
P356
10.1210/JCEM-68-6-1027
P407
P577
1989-06-01T00:00:00Z